Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 7, 2018; 24(25): 2733-2740
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2733
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2733
Figure 1 Levels of transforming growth factor-β in the serum of hepatocellular carcinoma patients and normal controls.
cP < 0.001. TGF-β: Transforming growth factor-β; HCC: Hepatocellular carcinoma.
- Citation: An Y, Gao S, Zhao WC, Qiu BA, Xia NX, Zhang PJ, Fan ZP. Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma. World J Gastroenterol 2018; 24(25): 2733-2740
- URL: https://www.wjgnet.com/1007-9327/full/v24/i25/2733.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i25.2733